JULY 2015 ARTICLE LIST >>
PharmaTutor (July- 2015)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 7)
Received On: 21/03/2015; Accepted On: 31/03/2015; Published On: 01/07/2015
AUTHORS: Shweta Vashist*, Jyoti Kaushik, Batra K. Sunil
Department of Pharmaceutics,
Hindu College of Pharmacy, Sonipat
shwetavashist55@gmail.com
ABSTRACT: Skin is the main target of topical and transdermal preparations. Major aim of transdermal drug delivery sytem is to cross the stratum corneum. Now-a-days we better know vesicles have importance in cellular communication. Niosomal carrier are systems containing soft vesicles, composed of non –ionic surfactant and an alternative to liposomes. They can entrap both hydrophilic and hydrophobic chemicals but these types of vesicles include the superior physical stability problems such as aggregation, fusion, and leakage of encapsulated drug. Proniosomes are provesicular approach which overcomes the limitations of vesicular system (Niosomes). Provesicular approach has been proposed to enhance the stability of vesicles. Proniosomes is a compact semi-solid liquid crystalline product of non- ionic surfactant easily formed on dissolving the surfactant in minimal amount of acceptable solvent and the least amount of aqueous phase. Proniosomes can be converted into niosomes in –situ by absorbing water from the skin.
How to cite this article: S Vashist, J Kaushik, SK Batra; A Review Article: Proniosomes; PharmaTutor; 2015; 3(7); 25-30
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Prajapati SK, Kumar S; Proniosomal gel of Flurbiprofen:Formulation and Evaluation; Journal of drug delivery and therapeutics; 2012, 2(1); 1-5.
2. Trupti anil udasi, vikran p.wankhade; proniosome: a novel approach to secular drug delivery system; Int j pharm pharm sci res; 2013; 3(1); 1-6.
3. Yoshiko T, Stemberg B, Florence AT.; preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60, and 80) and sorbitan trimester (span 85); Int j pharm. 1994; 105(1); 1-6.
4. ND Shukla, M Tiwari; Proniosomal Drug Delivery System– Clinical Applications.; Intenational Journal of Research in Pharmaceutical and Biomedical Sciences; 2011; 2 (3); 880-887.
5. D Akhilesh, G Hazel, JV Kamath; Proniosomes – A Propitious Provesicular Drug Carrier, Int. J. Pharm PharmSci Res 2011; 1 (3): 98-103.
6. AK Jha, R Kumar, S Kumar, SS Jha. Vesicular System -Carrier for Drug Delivery. Der Pharmacia Sinica 2011; 2(4); 192-202.
7. PK Gannu, R Pogaku;. Nonionic surfactant vesicular systems for effective drug delivery - an overview; Acta Pharmaceutica Sinica B 2011; 1(4); 208-219.
8. D Akhilesh, G Faishal, JV Kamath; Comparative Study of Carriers used in Proniosomes; Int.J Pharm Chem Sci 2012; 1(1); 164-173.
9. N Pandey.; Proniosomes and Ethosomes: New Prospect in Transdermal and Dermal Drug Delivery System; IJPSR 2011; 2(8); 1988-1996.
10. K Yadav, D Yadav, K Saroha, S Nanda, P Mathur; Proniosomal Gel: A provesicular approach for transdermal drug delivery; Der Pharmacia Lettre 2010, 2(4); 189-198.
11. Ashwani singh rawat, proniosome gel: anovel topical delivery system. Int j recent advances in pharm. Res: july 2011;3 1-10.
12. El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur J Pharm Biopharm., 2011; (1); 43-55.
13. Litha Thomas, vidya viswanad, formulaton and optimizationof clotrimazole-loaded proniosomal gel using 32 factorial design, sci pharm. Sep 2012; 80(3); 731-748.
14. wikipedia.org/wiki/Cholesterol.
15. JR Walve, BR Rane, NA Gujrathi, SR Bakaliwal, SP Pawar. Proniosomes: A Surrogated Carrier for Improved Transdermal Drug Delivery System, IJRAP 2011; 2 (3); 743 -750.
16. D Akhilesh, G Hazel, JV Kamath. Proniosomes – A Propitious Provesicular Drug Carrier, Int. J. Pharm PharmSciRes 2011; 1 (3): 98-103.
17. R Jukanti, D Annakula, MR Errabelli, S Bandari; Provesicular drug delivery systems: An overview and appraisal. Arch. Appl.Sci.Res. 2010; 2(4); 135-146.
18. Trottet L, Merly C, Mirza M, Davis AF; Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int j pharm. 2004; 2(4); 213-219.
19. Jain s, scarpe r, umamaheswari rb and jain nk; Pro-tranferosomes for effective transdermal delivery of norgesterel. Preparation and invitro characterization; Int j pharm sci. 2003; 65(2); 152-60.
20. Kamal saroha, sarabjeet singh, transdermal gels- an alternative vehicles for drug delivery. Int j pharm. Chem. Bio sci.; 2013, 3(3); 495-503.
21. Walve JR, bakliwal SR, Rane BR, Design; development and evaluation of a proniosomal transdermal drug delivery system for diclofenac; Int journal of pharm. Invention.
22. Shamsheer ahmad s, sabareesh m; formulation and evaluation of lisinopril dehydrate transdermal proniosomal gels; 2011; 01(08); 181-185.
23. Hu c and Rhodes dg. Proniosomes: a novel drug carrier preparation. Int j pharm. 2000: 206(1), 110-22.
24. Richard W. Korsmeyer, Robert Gurnya, Eric Doelkera, Pierre Buria, Nikolaos A. Peppas; Mechanism of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics. 1983; 15(1): 25-35.
25. circ.ahajournals.org/content/112/16/2436.full.pdf on line accessed on 15/08/2010.
.png)
